StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Roche Holding AG
Swiss Stock Exchange:RO.SW
Sector
Location
Market Cap
USD 256.82 B
Share Price
USD 338.18
Avg Daily Volume
28,734
Change (1 day)
-0.82%
Change (1 year)
-0.91%
Change (YTD)
13.02%
Roche Holding AG Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2024: USD 16.40 B
Roche Holding AG Selling, General, and Administrative Expenses (SG&A) is USD 16.40 B for the year ending December 31, 2024, a -7.20% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
-
Roche Holding AG Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2023 was USD 17.67 B, a 35.90% change year over year.
-
Roche Holding AG Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2022 was USD 13.01 B, a -0.04% change year over year.
-
Roche Holding AG Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2021 was USD 13.01 B, a -2.58% change year over year.
-
Roche Holding AG Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2020 was USD 13.36 B, a -1.86% change year over year.
Competitors
AbbVie Inc.
USD 184.85
ABBV
-4.41
-2.33%
Novo Nordisk A/S
USD 64.18
NOVO-B.CO
-0.20
-0.32%
Novartis AG
USD 114.67
NOVN.SW
-0.44
-0.38%
Abbott Laboratories
USD 124.42
ABT
+0.75
0.61%
AstraZeneca PLC
USD 138.01
AZN.L
-0.01
-0.01%
Merck & Co., Inc.
USD 79.31
MRK
-0.65
-0.81%
Amgen Inc.
USD 295.87
AMGN
+1.11
0.38%
Pfizer Inc.
USD 24.26
PFE
-0.21
-0.86%
Gilead Sciences, Inc.
USD 108.28
GILD
+0.06
0.06%
Vertex Pharmaceuticals Incorporated
USD 458.49
VRTX
-1.32
-0.29%
Sanofi
USD 96.20
SAN.PA
-0.42
-0.44%
Bristol-Myers Squibb Company
USD 46.69
BMY
-0.67
-1.42%
CSL Limited
USD 166.56
CSL.AX
-0.83
-0.50%
Chugai Pharmaceutical Co., Ltd.
USD 46.18
4519.T
-0.87
-1.84%
GSK plc
USD 18.13
GSK.L
+0.05
0.30%
Regeneron Pharmaceuticals, Inc.
USD 545.53
REGN
+3.01
0.56%
MERCK Kommanditgesellschaft auf Aktien
USD 128.35
MRK.DE
-0.23
-0.18%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.08
600276.SS
-0.10
-1.27%
Takeda Pharmaceutical Company Limited
USD 28.82
4502.T
-0.34
-1.16%
Alnylam Pharmaceuticals, Inc.
USD 320.52
ALNY
-0.01
-0.00%
Key Data
| Date | Selling, General, and Administrative Expenses (SG&A) | Research and Development (R&D) Expenses | Revenue | Revenue |
|---|
Competitors
AbbVie Inc.
USD 184.85
ABBV
-4.41
-2.33%
Novo Nordisk A/S
USD 64.18
NOVO-B.CO
-0.20
-0.32%
Novartis AG
USD 114.67
NOVN.SW
-0.44
-0.38%
Abbott Laboratories
USD 124.42
ABT
+0.75
0.61%
AstraZeneca PLC
USD 138.01
AZN.L
-0.01
-0.01%
Merck & Co., Inc.
USD 79.31
MRK
-0.65
-0.81%
Amgen Inc.
USD 295.87
AMGN
+1.11
0.38%
Pfizer Inc.
USD 24.26
PFE
-0.21
-0.86%
Gilead Sciences, Inc.
USD 108.28
GILD
+0.06
0.06%
Vertex Pharmaceuticals Incorporated
USD 458.49
VRTX
-1.32
-0.29%
Sanofi
USD 96.20
SAN.PA
-0.42
-0.44%
Bristol-Myers Squibb Company
USD 46.69
BMY
-0.67
-1.42%
CSL Limited
USD 166.56
CSL.AX
-0.83
-0.50%
Chugai Pharmaceutical Co., Ltd.
USD 46.18
4519.T
-0.87
-1.84%
GSK plc
USD 18.13
GSK.L
+0.05
0.30%
Regeneron Pharmaceuticals, Inc.
USD 545.53
REGN
+3.01
0.56%
MERCK Kommanditgesellschaft auf Aktien
USD 128.35
MRK.DE
-0.23
-0.18%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.08
600276.SS
-0.10
-1.27%
Takeda Pharmaceutical Company Limited
USD 28.82
4502.T
-0.34
-1.16%
Alnylam Pharmaceuticals, Inc.
USD 320.52
ALNY
-0.01
-0.00%